Strides Arcolab obtains USFDA approval for India facility

Strides Arcolab has announced that its oral dosage form manufacturing facility in Bangalore was latterly inspected by the United States Food and Drug Administration (USFDA) as part of Good manufacturing practices (GMP) compliance audit and the facility continues to be approved.

Strides Arcolab is a pharmaceutical company, headquartered in India, with a key focus on development and manufacture of generics and bio-pharmaceuticals. It is also among the world's largest manufacturers of specialty soft gelatin capsules. The core competence of the company is in the development and manufacture of niche and technically complex pharmaceutical products.

The last FDA inspection and approval of this facility manufacturing oral dosage forms was in the year 2011. The Bangalore facility is engaged in manufacturing of oral dosage forms such as tablets, capsules (both hard gelatin and soft gelatin) and sachets. The manufacturing plant supports important current and future submissions for the US market.